Precision population healthcare and beyond…

Life sciences need revolutionary precision insights to drive the future

C2-Ai provides unique insights across 100% of patients at a level of detail and scale that has never been seen in life sciences

C2-Ai is a leading company in the field of AI-backed healthcare analytics, committed to expanding the use of these powerful technologies in the life sciences industry for the benefit of patients. Our aim is to push the boundaries of what is possible with AI and machine learning, and we believe that these technologies have the potential to transform the way that treatments are developed and delivered. We offer cutting-edge tools and services to help our clients achieve success in their projects.
One key area where we are developing our expertise is in supporting research, development, and delivery of new treatments and therapies. We believe that AI and machine learning have the potential to revolutionize medical research and treatments, allowing for more targeted and equitable approaches that can match specific population needs geographically, socially, and ethnically.
One key area where we are developing our expertise is in supporting research, development, and delivery of new treatments and therapies. We believe that AI and machine learning have the potential to revolutionize clinical research and treatments, allowing for more targeted and equitable approaches that can match specific population needs geographically, socially, and ethnically.
 

SUPPORTING LIFE SCIENCES

Our suite of tools and services is designed to provide life sciences companies with the insights and support they need to achieve these goals. We offer personalized risk-adjustment tools that enable accurate analysis of patient outcomes and hospital performance. Additionally, we have forward-looking applications that can help to triage and manage patients more effectively.
We have demonstrated their effectiveness in wider applications in Primary and community-based care, supporting health systems, to understand the impacts of their projects and services. We have also expanded our offerings to support the precision population health agenda, with tools that can be used in primary and community care to understand and optimize service planning and configuration.

 

TRANSFORMING THE FUTURE OF LIFE SCIENCES – TOGETHER

In conclusion, at C2-Ai, we are passionate about the transformative power of AI and machine learning in the life sciences industry to benefit patients. Our suite of cutting-edge tools and services is designed to help our clients achieve success in their projects, whether it be in secondary care, public and population health,or precision medicine. We are committed to pushing the boundaries of what is possible with AI and machine learning and to supporting the development and delivery of new treatments and therapies that can benefit diverse populations of people worldwide.

Join us in this exciting journey to revolutionize the life sciences industry with the power of AI and machine learning.

Talk to our Life Sciences team
Get In Touch

Recent awards and recognition 

C2-Ai has won numerous awards and been published in peer reviewed journals

Recent awards and recognition 

C2-Ai has won numerous awards and been published in peer reviewed journals

Globally unique systems to transform healthcare…

Built by clinicians with globally recognised expertise in patient safety and clinical cost effectiveness
AI-backed platform covering 100% of patients across acute care (medicine, surgery, mat/neo, nursing based care) and beyond
No software integration or changes to clinical workflows required

Globally unique systems to transform healthcare…

Built by clinicians with globally recognised expertise in patient safety and clinical cost effectiveness
AI-backed platform covering 100% of patients across acute care (medicine, surgery, mat/neo, nursing based care) and beyond
No software integration or changes to clinical workflows required

Unique capabilities performing truly ground-breaking analysis…

900%

more issues detected across hospitals – clearly actionable for in-year ROI

9*10^453

permutations per patient delivering clincial risk assessment with exceptional accuracy – validated and published

3,300

AI-enhanced discrete metrics that matter – uncovering even hidden issues (failures to respond, omissions to treat)

Unique capabilities performing truly ground-breaking analysis…

900%

more issues detected across hospitals – clearly actionable for in-year ROI

9*10^453

permutations per patient delivering clincial risk assessment with exceptional accuracy – validated and published

3,300

AI-enhanced discrete metrics that matter – uncovering even hidden issues (failures to respond, omissions to treat)

Successfully delivering meaningful outcomes and insights…

$20m+

Potential direct cost savings per hospital (recurring per annum)

Unique

complication metrics for medical patients

8%

Reduction in emergency admissions

6-20,000

years of surgeon time served (NHS at 100% scale)

125

bed-days saved per 1,000 patients

50%+

reduction in Hospital Acquired Pneumonia/AKI

Successfully delivering meaningful outcomes and insights…

$20m+

Potential direct cost savings per hospital (recurring per annum)

Unique

complication metrics for medical patients

8%

Reduction in emergency admissions

6-20,000

years of surgeon time served (NHS at 100% scale)

125

bed-days saved per 1,000 patients

50%+

reduction in Hospital Acquired Pneumonia/AKI

Based on decades of research and extensive hospital data

400m+

patient records processed from 46 countries

30yrs

of research and 15 years of real world deployment across 11 countries

30%

adoption in NHS ICS regions as well as government + regulators + ‘for profit’ hospitals in US 

Based on decades of research and extensive hospital data

400m+

patient records processed from 46 countries

30yrs

of research and 15 years of real world deployment across 11 countries

30%

adoption in NHS ICS regions as well as government + regulators + ‘for profit’ hospitals in US 

4bn+

combinations of operative type and physiology

1000

person years of surgeon time could be saved 

50%

Reduction in harm and mortality

6

weeks of triage time saved per surgeon

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Save